Optical imaging for breast cancer prescreening
Anuradha Godavarty,1 Suset Rodriguez,1 Young-Jin Jung,2 Stephanie Gonzalez1 1Optical Imaging Laboratory, Department of Biomedical Engineering, Florida International University, Miami, FL, USA; 2Department of Radiological Science, Dongseo University, Busan, South Korea Abstract: Breast cancer prescr...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/330ab409c73040b180b454f6d886af18 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:330ab409c73040b180b454f6d886af18 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:330ab409c73040b180b454f6d886af182021-12-02T06:29:50ZOptical imaging for breast cancer prescreening1179-1314https://doaj.org/article/330ab409c73040b180b454f6d886af182015-07-01T00:00:00Zhttp://www.dovepress.com/optical-imaging-for-breast-cancer-prescreening-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314Anuradha Godavarty,1 Suset Rodriguez,1 Young-Jin Jung,2 Stephanie Gonzalez1 1Optical Imaging Laboratory, Department of Biomedical Engineering, Florida International University, Miami, FL, USA; 2Department of Radiological Science, Dongseo University, Busan, South Korea Abstract: Breast cancer prescreening is carried out prior to the gold standard screening using X-ray mammography and/or ultrasound. Prescreening is typically carried out using clinical breast examination (CBE) or self-breast examinations (SBEs). Since CBE and SBE have high false-positive rates, there is a need for a low-cost, noninvasive, non-radiative, and portable imaging modality that can be used as a prescreening tool to complement CBE/SBE. This review focuses on the various hand-held optical imaging devices that have been developed and applied toward early-stage breast cancer detection or as a prescreening tool via phantom, in vivo, and breast cancer imaging studies. Apart from the various optical devices developed by different research groups, a wide-field fiber-free near-infrared optical scanner has been developed for transillumination-based breast imaging in our Optical Imaging Laboratory. Preliminary in vivo studies on normal breast tissues, with absorption-contrasted targets placed in the intramammary fold, detected targets as deep as 8.8 cm. Future work involves in vivo imaging studies on breast cancer subjects and comparison with the gold standard X-ray mammography approach. Keywords: diffuse optical imaging, near-infrared, hand-held devices, breast cancer, prescreening, early detection Godavarty ARodriguez SJung YJGonzalez SDove Medical PressarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol 2015, Iss default, Pp 193-209 (2015) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Godavarty A Rodriguez S Jung YJ Gonzalez S Optical imaging for breast cancer prescreening |
description |
Anuradha Godavarty,1 Suset Rodriguez,1 Young-Jin Jung,2 Stephanie Gonzalez1 1Optical Imaging Laboratory, Department of Biomedical Engineering, Florida International University, Miami, FL, USA; 2Department of Radiological Science, Dongseo University, Busan, South Korea Abstract: Breast cancer prescreening is carried out prior to the gold standard screening using X-ray mammography and/or ultrasound. Prescreening is typically carried out using clinical breast examination (CBE) or self-breast examinations (SBEs). Since CBE and SBE have high false-positive rates, there is a need for a low-cost, noninvasive, non-radiative, and portable imaging modality that can be used as a prescreening tool to complement CBE/SBE. This review focuses on the various hand-held optical imaging devices that have been developed and applied toward early-stage breast cancer detection or as a prescreening tool via phantom, in vivo, and breast cancer imaging studies. Apart from the various optical devices developed by different research groups, a wide-field fiber-free near-infrared optical scanner has been developed for transillumination-based breast imaging in our Optical Imaging Laboratory. Preliminary in vivo studies on normal breast tissues, with absorption-contrasted targets placed in the intramammary fold, detected targets as deep as 8.8 cm. Future work involves in vivo imaging studies on breast cancer subjects and comparison with the gold standard X-ray mammography approach. Keywords: diffuse optical imaging, near-infrared, hand-held devices, breast cancer, prescreening, early detection |
format |
article |
author |
Godavarty A Rodriguez S Jung YJ Gonzalez S |
author_facet |
Godavarty A Rodriguez S Jung YJ Gonzalez S |
author_sort |
Godavarty A |
title |
Optical imaging for breast cancer prescreening |
title_short |
Optical imaging for breast cancer prescreening |
title_full |
Optical imaging for breast cancer prescreening |
title_fullStr |
Optical imaging for breast cancer prescreening |
title_full_unstemmed |
Optical imaging for breast cancer prescreening |
title_sort |
optical imaging for breast cancer prescreening |
publisher |
Dove Medical Press |
publishDate |
2015 |
url |
https://doaj.org/article/330ab409c73040b180b454f6d886af18 |
work_keys_str_mv |
AT godavartya opticalimagingforbreastcancerprescreening AT rodriguezs opticalimagingforbreastcancerprescreening AT jungyj opticalimagingforbreastcancerprescreening AT gonzalezs opticalimagingforbreastcancerprescreening |
_version_ |
1718399866022920192 |